New drug Rina-S shows promise in lung cancer trial

NCT ID NCT07288177

Recruiting now Disease control Sponsor: Genmab Source: ClinicalTrials.gov ↗

First seen Dec 29, 2025 · Last updated May 01, 2026 · Updated 18 times

Summary

This study tests a new drug called Rina-S in about 240 people with advanced non-small cell lung cancer. The goal is to see if Rina-S can shrink tumors or slow cancer growth. All participants receive the active drug, and treatment may continue as long as it helps and side effects are manageable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Astera Cancer Care
RECRUITING

East Brunswick, New Jersey, 08816, United States
Japan Community Health Care Organization Chukyo Hospital
RECRUITING

Nagoya, Minami Ward, Japan
Kyoto Prefectural University of Medicine
RECRUITING

Kyoto, Kyoto, Japan
NHO Kinki Chuo Chest Medical Center
RECRUITING

Sakai, Osaka, Japan
Nebraska Hematology-Oncology
RECRUITING

Lincoln, Nebraska, 68506, United States
ONE Onc: New York Oncology Hematology
RECRUITING

Albany, New York, 12206, United States
Providence Medical Foundation (St. Joseph Heritage Healthcare)
RECRUITING

Santa Rosa, California, 95403, United States
Virginia Cancer Specialists
RECRUITING

Fairfax, Virginia, 22031, United States

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER (NSCLC) NON-SMALL CELL LUNG CANCER (NSCLC)